
In SURMOUNT-ADOLESCENTS, tirzepatide cut BMI 18.5% at 72 weeks vs a 0.5% rise with placebo in adolescents with obesity.
Two of the five new additions to the advisory council of the National Institute of Allergy and Infectious Diseases are pediatricians: Ann Arvin, MD, and Christel Uittenbogaart, MD....






